Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Bayer logo — Global enterprise with core competencies in the Life Science...

Bayer

Global enterprise with core competencies in the Life Science fields of health care and agriculture

Founded 1863 Germany Leverkusen, Germany 95915 employees IPO Total: $457.30M Biotechnology, Health Care +2

General Information

Company Name Bayer
Founded Year 1863
Location Germany Leverkusen, Germany
Employees 95915
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage IPO
Business Model B2B, B2C
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Bayer. To contact Bayer, visit bayer.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Bayer

Bayer is an established global enterprise founded in 1863, with core competencies in Biotechnology, Health Care, Life Sciences, and Pharmaceuticals. Headquartered in Germany, the company's vision is encapsulated in its slogan: "Global enterprise with core competencies in the Life Science fields of health care and agriculture."

Bayer designs products and services aimed at addressing essential human needs in health and nutrition, tackling challenges presented by an aging and growing global population. Their approach focuses on sustainable development, pioneering scientific advancements to enhance healthcare and nutrition globally.

Recently, Bayer secured a $192.30M Post IPO Debt investment, with notable investment from Brasil Capital, signaling strong market confidence and support for its ongoing projects and growth initiatives.

Taxonomy: Life Science, Nutrition, Pharmaceuticals, Consumer Health, Crop Science, Sustainable Development, Scientific Knowledge, Patient Care, Food Security, Digital Farming, Research and Innovation, Science for Better, Aging Population, Environmental Impact

Services & Products

Pharmaceuticals development
Consumer health products
Agricultural solutions
Innovation in life sciences

Target Customers

Healthcare Professionals Farmers Patients Researchers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt $192.30M 1
Brasil Capital
Brasil Capital
01 Jan 2026
Post-IPO Debt Fr.265.00M -
01 Sep 2025
Grant Undisclosed 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
01 Nov 2022
IPO Undisclosed -
01 Dec 1996

Bayer Alternatives & Competitors

View All Alternatives
Bayer vs
Boehringer Ingelheim
Boehringer Ingelheim Germany

Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals

Late Stage
47532 employees
Biotechnology, Health Care
Bayer vs
DSM
DSM The Netherlands

inactive - follow dsm-firmenich

IPO
12119 employees
Biotechnology, Health Care
Bayer vs
mend™
mend™ United States

Advancing patient healing through clinically supported nutrition and care.

Series A
56 employees
Biotechnology, Health Care
View all alternatives

FAQ About Bayer

Global enterprise with core competencies in the Life Science fields of health care and agriculture
Bayer was founded in 1863.
Bayer is headquartered in Leverkusen, Germany.
Bayer operates in Biotechnology, Health Care, Life Sciences and Pharmaceutical. Its work centres on Life Science, Nutrition, Pharmaceuticals and Consumer Health. Its customers include Healthcare Professionals, Farmers and Patients.
Bayer has a B2B and B2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Bayer has approximately 95915 employees.
Bayer has completed 4 funding rounds, raising a total of $457.30M. The latest funding stage is IPO.
Bayer offers: Pharmaceuticals development, Consumer health products, Agricultural solutions, Innovation in life sciences.
Top alternatives and competitors to Bayer include Boehringer Ingelheim, DSM, mend™, Eli Lilly and Company, Crimson Publishers. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bayer and Boehringer Ingelheim are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bayer, https://bouncewatch.com/company/bayer-5, updated 1 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes